<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02816398</url>
  </required_header>
  <id_info>
    <org_study_id>01-0012-01</org_study_id>
    <nct_id>NCT02816398</nct_id>
  </id_info>
  <brief_title>Catheter System Feasibility Clinical Trial</brief_title>
  <official_title>Vessel-Select Catheter System Feasibility Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Avenu Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospital Universitario Dr. Jose E. Gonzalez</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Avenu Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Feasibility clinical study to evaluate the safety and effectiveness of the catheter system
      for the percutaneous creation of an arteriovenous fistula for patients with end stage renal
      disease requiring dialysis access.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Actual">January 2016</completion_date>
  <primary_completion_date type="Actual">October 2015</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patency</measure>
    <time_frame>6 weeks</time_frame>
    <description>Arteriovenous fistula is patent and eligible for maturation assistance to achieve clinical access flow rate.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Dialysis access</measure>
    <time_frame>6 weeks</time_frame>
    <description>Arteriovenous fistula is mature and patient has started dialysis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Access flow rate</measure>
    <time_frame>6 weeks</time_frame>
    <description>Arteriovenous fistula is mature and has achieved a minimu clinically acceptable access flow rate to support dialysis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Additional interventions</measure>
    <time_frame>12 weeks</time_frame>
    <description>The quantity of interventions required to achieve maturation and initiation of dialysis.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">27</enrollment>
  <condition>Renal Insufficiency, Chronic</condition>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Interventional use of experimental Ellipsys catheter system for percutaneous creation of an arteriovenous fistula</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Percutaneous creation of an arteriovenous fistula</intervention_name>
    <description>Use of catheter system for percutaneous creation of an arteriovenous fistula</description>
    <arm_group_label>Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients deemed medically eligible for AV fistula creation per institutional
             guidelines and/or clinical judgment

          -  Patients diagnosed with chronic kidney disease classification stage IV or V

          -  Adequate quality vein &gt;= 2 mm with confirmed clinically significant outflow based on
             pre-operative assessment

          -  Adequate quality radial artery &gt;= 2 mm based on pre-operative assessment

          -  Adequate collateral arterial perfusion

          -  Radial artery-adjacent vein proximity &lt; = 1.5 mm

          -  Able to provide informed consent

          -  Able to travel to institution for follow up examination

          -  Able to intraoperatively place an .014&quot; guidewire in artery

        Exclusion Criteria:

          -  Suspected skin disease

          -  Immunocompromised patients (e.g. HIV positive)

          -  Edema of extremities

          -  Current diagnosis of carcinoma

          -  Pregnancy or currently breast feeding

          -  Diagnosed hypercoaguable state

          -  Active infection

          -  Evidence of vascular disease at target site

          -  Pre-existing vascular disease that could confound study results

          -  Vessel tortuosity or spasm preventing placement of .014&quot; guidewire
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 23, 2016</study_first_submitted>
  <study_first_submitted_qc>June 24, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 28, 2016</study_first_posted>
  <last_update_submitted>June 27, 2016</last_update_submitted>
  <last_update_submitted_qc>June 27, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 29, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

